PubRank

Peter J Whitehouse

Author PubWeight™ 41.40‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Disclosure of APOE genotype for risk of Alzheimer's disease. N Engl J Med 2009 6.43
2 Who seeks genetic susceptibility testing for Alzheimer's disease? Findings from a multisite, randomized clinical trial. Genet Med 2004 2.44
3 Changing perspectives regarding late-life dementia. Nat Rev Neurol 2009 2.04
4 Genetic risk assessment for adult children of people with Alzheimer's disease: the Risk Evaluation and Education for Alzheimer's Disease (REVEAL) study. J Geriatr Psychiatry Neurol 2005 2.03
5 Reasons for seeking genetic susceptibility testing among first-degree relatives of people with Alzheimer disease. Alzheimer Dis Assoc Disord 2003 1.79
6 ADCS Prevention Instrument Project: overview and initial results. Alzheimer Dis Assoc Disord 2006 1.70
7 Health-related resource use and costs in elderly adults with and without mild cognitive impairment. J Am Geriatr Soc 2013 1.59
8 Disclosing Pleiotropic Effects During Genetic Risk Assessment for Alzheimer Disease: A Randomized Trial. Ann Intern Med 2016 1.47
9 Intergenerational volunteering and quality of life for persons with mild-to-moderate dementia: results from a 5-month intervention study in the United States. J Am Geriatr Soc 2010 1.26
10 ADCS Prevention Instrument Project: pharmacoeconomics: assessing health-related resource use among healthy elderly. Alzheimer Dis Assoc Disord 2006 1.08
11 Incorporating ethnicity into genetic risk assessment for Alzheimer disease: the REVEAL study experience. Genet Med 2008 1.08
12 The evolving classification of dementia: placing the DSM-V in a meaningful historical and cultural context and pondering the future of "Alzheimer's". Cult Med Psychiatry 2011 1.06
13 Recall of disclosed apolipoprotein E genotype and lifetime risk estimate for Alzheimer's disease: the REVEAL Study. Genet Med 2006 1.03
14 B-vitamins and fatty acids in the prevention and treatment of Alzheimer's disease and dementia: a systematic review. J Alzheimers Dis 2010 0.99
15 Informed consent for Alzheimer's disease clinical trials: a survey of clinical investigators. IRB 2003 0.98
16 Uncertain progress on the fuzzy boundaries of Alzheimer's disease: reading between the guidelines. J Alzheimers Dis 2011 0.94
17 ADCS Prevention Instrument Project: quality of life assessment (QOL). Alzheimer Dis Assoc Disord 2006 0.92
18 The War (on Terror) on Alzheimer's. Dementia (London) 2012 0.91
19 Empirical research on informed consent with the cognitively impaired. IRB 2004 0.89
20 Marketplace of memory: what the brain fitness technology industry says about us and how we can do better. Gerontologist 2011 0.89
21 Empirical assessment of a research advance directive for persons with dementia and their proxies. J Am Geriatr Soc 2007 0.88
22 Further limits on labels for cognitive impairment: can we diagnose what we don't know? Am J Geriatr Psychiatry 2011 0.87
23 Anti-aging medicine: can consumers be better protected? Gerontologist 2004 0.84
24 Discourse ethics: research, dementia, and communication. Alzheimer Dis Assoc Disord 1994 0.82
25 Classification of the dementias. Lancet 2003 0.81
26 Dementia, diagnostic disclosure, and self-reported health status. J Am Geriatr Soc 2007 0.81
27 Quality of life in dementia: ten years later. Alzheimer Dis Assoc Disord 2003 0.80
28 Renovating Alzheimer's: "constructive" reflections on the new clinical and research diagnostic guidelines. Gerontologist 2012 0.79
29 Special care unit research: ethical issues. Alzheimer Dis Assoc Disord 1994 0.79
30 Health state valuation in mild to moderate cognitive impairment: feasibility of computer-based, direct patient utility assessment. Med Decis Making 2008 0.78
31 Variable judgments of decisional capacity in cognitively impaired research subjects. J Am Geriatr Soc 2008 0.77
32 Susceptibility testing for Alzheimer's disease: race for the future. Lancet Neurol 2002 0.76
33 Alzheimer's Disease Cooperative Study Prevention Instrument Project assessing resource use and volunteer and paid work in healthy elders: a longitudinal study. J Am Geriatr Soc 2014 0.75
34 Guidelines for addressing ethical and legal issues in Alzheimer disease research: a position paper. Alzheimer Dis Assoc Disord 1994 0.75
35 Introduction (to 6 articles and a position paper on ethical and legal issues in Alzheimer disease research) Alzheimer Dis Assoc Disord 1994 0.75
36 The future of dementia: a case of hardening of the categories. Am J Geriatr Psychiatry 2010 0.75
37 Chasing the "white whale" of Alzheimer's. J Am Geriatr Soc 2014 0.75
38 Through the amyloid gateway. Lancet 2012 0.75
39 "Occupy nature": passing activism across generations. J Am Geriatr Soc 2012 0.75
40 Readdressing our moral relationship to nonhuman creatures: commentary on "A dialogue on species-specific rights: humans and animals in bioethics. Camb Q Healthc Ethics 1997 0.75